Open access
Open access
Powered by Google Translator Translator

Thu July 30 – 10 Stories of The Day!

30 Jul, 2020 | 10:55h | UTC

 

1 – Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia

 

2 – Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US – JAMA

Editorial: COVID-19 and School Closures

Author Interview: COVID-19 and School Reopenings

Commentaries: School closures in spring linked to drastic decrease in Covid-19 cases and deaths – STAT AND Schools closures in spring were linked to reductions in Covid-19 cases and deaths, study says – CNN AND Closing schools in March may have saved the lives of 40,000 Americans, a new analysis found – Business Insider AND School Closures in the Spring Saved Lives, Study Asserts – The New York Times

 

3 – Reopening K-12 Schools During the COVID-19 Pandemic: A Report From the National Academies of Sciences, Engineering, and Medicine – JAMA

Original report: Reopening K-12 Schools During the COVID-19 Pandemic – National Academies of Sciences, Engineering, and Medicine

 

4 – How Schools & Parents Should Navigate Reopening During COVID-19 – Infectious Diseases Society of America

 

5 – Reopening Primary Schools during the Pandemic – New England Journal of Medicine

 

6 – Opening Schools Won’t Be Easy, but Here’s How to Do It Safely – The New York Times

 

7 – What Do We Know About Children and Coronavirus Transmission? – Kaiser Family Foundation

 

8 –  Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing – New England Journal of Medicine

 

9 – SARS-CoV-2 viral load dynamics, duration of viral shedding and infectiousness: a living systematic review and meta-analysis – medRxiv

 

10 –COVID-19 Updates / 30 July 2020 Edition

30 July 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.